Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$462,432
-$36,296 QoQ
Shares Held
19,204
+8.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,806
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2025CallValue
$12,670
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $88,098,662 across 9 Drug Manufacturers - General names. PFE ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,814 | $65,745,561 | |
| 2 | NVO |
Novo Nordisk A S
|
247,912 | $11,884,901 | |
| 3 | ABBV |
AbbVie Inc.
|
19,460 | $4,896,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,894 | $2,813,379 | |
| 5 | JNJ |
Johnson & Johnson
|
3,240 | $822,862 | |
| 6 | NVS |
Novartis AG
|
5,144 | $806,167 | |
| 7 | PFE |
Pfizer Inc
This page
|
19,204 | $462,432 | |
| 8 | AMGN |
Amgen Inc
|
960 | $347,635 |
All Filings in PFE
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $462,432 | 19,204 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $498,728 | 17,761 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $671,802 | 26,980 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $758,717 | 29,777 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $724,679 | 29,896 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $677,566 | 26,739 | Shares | Sole | 2025-05-12 | |
| 2025-03-31 | $12,670 | 500 | Call | Sole | 2025-05-12 | |
| 2024-12-31 | $29,183 | 1,100 | Call | Sole | 2025-01-17 | |
| 2024-12-31 | $764,090 | 28,801 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $790,872 | 27,328 | Shares | Sole | 2024-10-25 | |
| 2024-09-30 | $1,996,860 | 69,000 | Call | Sole | 2024-10-25 | |
| 2024-06-30 | $2,196,430 | 78,500 | Call | Sole | 2024-07-24 | |
| 2024-06-30 | $724,206 | 25,883 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $604,367 | 21,779 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $625,318 | 21,720 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,114,943 | 33,613 | Shares | Sole | 2023-10-16 | |
| 2023-09-30 | $497,550 | 15,000 | Put | Sole | 2023-10-16 | |
| 2023-06-30 | $1,144,122 | 31,192 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $612,000 | 15,000 | Put | Sole | 2023-04-21 | |
| 2023-03-31 | $1,367,004 | 33,505 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,474,994 | 28,786 | Shares | Sole | 2023-01-27 | |
| 2022-12-31 | $768,600 | 15,000 | Put | Sole | 2023-01-27 | |
| 2022-09-30 | $1,301,334 | 29,738 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,503,639 | 28,679 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,479,327 | 28,575 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $7,218,921 | 122,251 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,007,783 | 116,433 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $4,573,104 | 116,780 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $4,324,449 | 119,361 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $4,456,439 | 121,066 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $3,247,176 | 88,479 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,346,554 | 71,760 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,637,416 | 50,166 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||